Abstract
Abnormalities in hepatic function have become one of the most common complications occurring among human immunodeficiency virus (HIV)-infected individuals receiving highly active antiretroviral therapy (HAART), and liver disease has become an increasingly important cause of morbidity and mortality in HIV-infected patients. We present a case of a patient with HIV infection and hepatotoxicity that exemplifies the complications currently observed during the treatment of such patients. Hepatotoxicity can be a result of several factors, including a direct effect of HAART, substance abuse, and coinfection with either hepatitis C virus (HCV) or hepatitis B virus. Imaging studies may be helpful in determining the etiology; however, a liver biopsy is often necessary to be able to more accurately determine the relative contributions of different processes. Although coinfection with HCV and HIV has become a common clinical problem, optimal treatment of such patients remains to be defined and must be individualized to maximize benefit and tolerance.
Citations
Oct 17, 2007·Digestive Diseases and Sciences·Richard K SterlingDaniel Nixon
Feb 25, 2005·Current Infectious Disease Reports·Benigno Rodriguez, David A Bobak
Oct 13, 2012·Journal of Clinical Gastroenterology·Richard K SterlingElizabeth M Brunt
Feb 19, 2008·AIDS Care·J G BaillargeonJ S Pulvino
Apr 24, 2010·Emergency Medicine Clinics of North America·Daniel M LugassyLewis S Nelson
Mar 25, 2008·Annals of Emergency Medicine·Arvind VenkatCory P Heidelberger
May 24, 2006·Journal of Substance Abuse Treatment·Lawrence S BrownCharles Madray
Jan 13, 2006·Gastroenterology·Jules L Dienstag, John G McHutchison
Apr 12, 2014·AIDS Care·Marco PereiraMaria Cristina Canavarro
Aug 11, 2016·Journal of Behavioral Medicine·Marco Pereira, Renata Fialho
Mar 2, 2006·The Annals of Pharmacotherapy·Christine A Hughes, Stephen D Shafran
Nov 23, 2016·World Journal of Hepatology·Daniel FusterRobert Muga
Jul 6, 2021·Journal of Clinical and Translational Hepatology·Sandeep SatsangiParul Kodan